Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats

J Gastroenterol Hepatol. 2014 Jan;29(1):215-22. doi: 10.1111/jgh.12389.

Abstract

Background and aim: Oxidative stress and inflammation play important roles in the progression from simple fatty liver to non-alcoholic steatohepatitis (NASH). The aim of this work was to investigate whether treatment with hydrogen sulfide (H2 S) prevented NASH in rats through abating oxidative stress and suppressing inflammation.

Methods: A methionine-choline-deficient (MCD) diet rat model was prepared. Rats were divided into three experimental groups and fed for 8 weeks as follows: (i) control rats; (ii) MCD-diet-fed rats; (iii) MCD-diet-fed rats treated with NaHS (intraperitoneal injection of 0.1 mL/kg/day of 0.28 mol/L NaHS, a donor of H2 S).

Results: MCD diet impaired hepatic H2 S biosynthesis in rats. Treatment with H2 S prevented MCD-diet-induced NASH, as evidenced by hematoxylin and eosin staining, reduced apoptosis and activities of alanine aminotransferase and aspartate aminotransferase, and attenuated hepatic fat accumulation in rats. Treatment with H2 S abated MCD-diet-induced oxidative stress through reducing cytochrome p4502E1 expression, enhancing heme oxygenase-1 expression, and suppressing mitochondrial reactive oxygen species formation, and suppressed MCD-diet-induced inflammation through suppressing activated nuclear factor κB signaling and reducing interleukin-6 and tumor necrosis factor α expressions. In addition, treatment of MCD-diet fed rats with H2 S had a beneficial modulation on expression profiles of fatty acid metabolism genes in livers.

Conclusions: Treatment with H2 S prevented NASH induced by MCD diet in rats possibly through abating oxidative stress and suppressing inflammation.

Keywords: hydrogen sulfide; inflammation; methionine-choline deficient diet; non-alcoholic steatohepatitis; oxidative stress.

MeSH terms

  • Animals
  • Choline Deficiency / complications*
  • Cytochrome P-450 CYP2E1 / metabolism
  • Disease Models, Animal
  • Disease Progression
  • Fatty Liver / complications
  • Fatty Liver / etiology*
  • Fatty Liver / prevention & control*
  • Heme Oxygenase-1 / metabolism
  • Hydrogen Sulfide / metabolism
  • Hydrogen Sulfide / pharmacology
  • Hydrogen Sulfide / therapeutic use*
  • Inflammation / complications
  • Inflammation / prevention & control
  • Interleukin-6 / metabolism
  • Liver / metabolism
  • Male
  • Methionine / deficiency*
  • Mitochondria, Liver / metabolism
  • NF-kappa B / metabolism
  • Oxidative Stress / drug effects
  • Rats
  • Rats, Wistar
  • Reactive Oxygen Species / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Interleukin-6
  • NF-kappa B
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Methionine
  • Cytochrome P-450 CYP2E1
  • Heme Oxygenase-1
  • Hydrogen Sulfide